Novel CTX-M β-lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 5, 2009, Pages 895-900

  Liu, Wen'en ^a   Chen, Lamei ^a   Li, Hongling ^a   Duan, Huili ^a   Zhang, Yunli ^a   Liang, Xianghui ^a   Li, Xian ^a   Zou, Mingxiang ^a   Xu, Li ^b   Hawkey, Peter M ^b,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

BlaCTX M; ESBLs; Hunan province

Indexed keywords

AMIKACIN; BETA LACTAMASE SHV; CEFOTAXIME; CEFOTAXIME M TYPE EXTENDED SPECTRUM BETA LACTAMASE; CEFTAZIDIME; CEFTRIAXONE; EXTENDED SPECTRUM BETA LACTAMASE; MEROPENEM; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CHINA; CITROBACTER FREUNDII; CLONAL VARIATION; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENOTYPE; INCIDENCE; KLEBSIELLA PNEUMONIAE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PROTEUS VULGARIS; PROVIDENCIA STUARTII; RANDOM AMPLIFIED POLYMORPHIC DNA;

BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CHINA; DNA, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENOTYPE; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; SEQUENCE ANALYSIS, DNA;

EID: 64649104806     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp068     Document Type: Article

References (32)

1. Canton R, Novais A, Valverde A et al. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008; 14 Suppl 1: 144-53.
2. Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: An emerging public-health concern. Lancet Infect Dis 2008; 8: 159-66.
3. Livermore DM, Hawkey PM. CTX-M: Changing the face of ESBLs in the UK. J Antimicrob Chemother 2005; 56: 451-4.
4. Bell JM, Turnidge JD, Gales AC et al. Prevalence of extended spectrum β-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: Regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn Microbiol Infect Dis 2002; 42: 193-8.
5. Hawkey PM. Prevalence and clonality of extended-spectrum β-lactamases in Asia. Clin Microbiol Infect 2008; 14 Suppl 1: 159-65.
6. Hirakata Y, Matsuda J, Miyazaki Y et al. Regional variation in the prevalence of extended-spectrum β-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn Microbiol Infect Dis 2005; 52: 323-9.
7. Cheng Y, Li Y, Chen M. A plasmid-mediated SHV type extended-spectrum β-lactamase in Beijing isolate of Enterobacter gergoviae. Wei Sheng Wu Xue Bao 1994; 34: 106-12.
8. Chanawong A, M'Zali FH, Heritage J et al. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother 2002; 46: 630-7.
9. Wang H, Kelkar, S, Wu W et al. Clinical isolates of Enterobacteriaceae producing extended-spectrum β-lactamases: Prevalence of CTX-M-3 at a hospital in China. Antimicrob Agents Chemother 2003; 47: 790-3.
10. Lewis JS, Herrera M, Wickes B et al. First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother 2007; 51: 4015-21.
11. Pitout JD, Church DL, Gregson DB et al. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary health region: emergence of CTX-M-15-producing isolates. Antimicrob Agents Chemother 2007; 51: 1281-6.
12. Yu Y, Ji S, Chen Y et al. Resistance of strains producing extended-spectrum β-lactamases and genotype distribution in China. J Infect 2007; 54: 53-7.
13. Munday CJ, Xiong J, Li C et al. Dissemination of CTX-M type β-lactamases in Enterobacteriaceae isolates in the People's Republic of China. Int J Antimicrob Agents 2004; 23: 175-80.
14. Gniadkowski M. Evolution of extended-spectrum β-lactamases by mutation. Clin Microbiol Infect 2008; 14 Suppl 1: 11-32.
15. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Informational Supplement M100-S18. CLSI, Wayne, PA, USA, 2008.
16. Munday CJ, Whitehead GM, Todd NJ et al. Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum β-lactamases in York, UK. J Antimicrob Chemother 2004; 54: 628-33.
17. CTX-M genes by multiplex PCR assay. J Med Microbiol 2005; 54: 1183-7.
18. Xu L, Ling T, Boese K et al. Rapid genotyping of CTX-M β-lactamases by denaturing high-performance liquid chromatography. In: Abstracts of the Forty-fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, 2005. Abstract C2-771, p. 115. American Society for Microbiology, Washington, DC, USA.
19. Munoz MA, Welcome FL, Schukken YH et al. Molecular epidemiology of two Klebsiella pneumoniae mastitis outbreaks on a dairy farm in New York State. J Clin Microbiol 2007; 45: 3964-71.
20. Liu G, Ling BD, Zeng Y et al. Molecular characterization of extended-spectrum β-lactamases produced by clinical isolates of Enterobacter cloacae from a teaching hospital in China. Jpn J Infect Dis 2008; 61: 286-9.
21. Ling TK, Xiong J, Yu Y et al. Multicenter antimicrobial susceptibility survey of Gram-negative bacteria isolated from patients with community-acquired infections in the People's Republic of China. Antimicrob Agents Chemother 2006; 50: 374-8.
22. Jacoby GA, Medeiros AA, O'Brien TF et al. Broad-spectrum, transmissible β-lactamases. N Engl J Med 1988; 319: 723-4.
23. Liu RY, Tung JC, Ke SC et al. Molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates in a district hospital in Taiwan. J Clin Microbiol 1998; 36: 2759-62.
24. Yan JJ, Wu SM, Tsai SH et al. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan. Antimicrob Agents Chemother 2000; 44: 1438-42.
25. Heritage J, M'Zali FH, Gascoyne-Binzi D et al. Evolution and spread of SHV extended-spectrum β-lactamases in Gram-negative bacteria. J Antimicrob Chemother 1999; 44: 309-18.
26. Ryoo NH, Kim EC, Hong SG et al. Dissemination of SHV-12 and CTX-M-type extended-spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J Antimicrob Chemother 2005; 56: 698-702.
27. Yu WL, Chuang YC, Walther-Rasmussen J. Extended-spectrum β-lactamases in Taiwan: Epidemiology, detection, treatment and infection control. J Microbiol Immunol Infect 2006; 39: 264-77.
28. Xiong Z, Zhu D, Wang F et al. Investigation of extended-spectrum β-lactamase in Klebsiella pneumoniae and Escherichia coli from China. Diagn Microbiol Infect Dis 2002; 44: 195-200.
29. Yao F, Qian Y, Chen S et al. Incidence of extended-spectrum β-lactamases and characterization of integrons in extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated in Shantou, China. Acta Biochim Biophys Sin (Shanghai) 2007; 39: 527-32.
30. Ho PL, Poon WW, Loke SL et al. Community emergence of CTX-M type extended-spectrum β-lactamases among urinary Escherichia coli from women. J Antimicrob Chemother 2007; 60: 140-4.
31. Rossolini GM, D'Andrea MM, Mugnaioli C. The spread of CTX-M-type extended-spectrum β-lactamases. Clin Microbiol Infect 2008; 14 Suppl 1: 33-41.
32. Bonnet R. Growing group of extended-spectrum β-lactamases: The CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1-14.